Cargando…

Galectin-3 is not useful for hepatocellular carcinoma surveillance in cirrhotic patients but it may be a marker of cirrhosis development

AIM OF THE STUDY: Ultrasound surveillance for hepatocellular carcinoma (HCC) among cirrhotic patients is the currently used modality but it is operator dependent. Combining a tumor marker with ultrasound may improve sensitivity for early HCC detection. Our aim was to assess the galectin-3 level amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassar, Eman Saad, Elkalbashawy, Yomna Abdelrazek, Kamal, Ahmed, Zakaria, Nermine Hossam Eldin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122102/ https://www.ncbi.nlm.nih.gov/pubmed/34027118 http://dx.doi.org/10.5114/ceh.2021.104385

Ejemplares similares

Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
por: Liu, Hongqun, et al.
Publicado: (2023)

Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?
por: Dash, Subhash Chandra, et al.
Publicado: (2023)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Assessment of serum CXCL9 and pentraxin 3 as novel markers for hepatocellular carcinoma in cirrhotic hepatitis C patients
por: Mehanna, Rafik Gabbour, et al.
Publicado: (2023)

Molecular Profiles of HCV Cirrhotic Tissues Derived in a Panel of Markers with Clinical Utility for Hepatocellular Carcinoma Surveillance
por: Gehrau, Ricardo C., et al.
Publicado: (2012)

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma
por: Fu, Siyu, et al.
Publicado: (2023)

Hepatocellular carcinoma among cirrhotics - Utility of screening and surveillance programs - Review article -
por: Opriță, R, et al.
Publicado: (2014)

Diastolic Dysfunction and Severity of Cirrhosis in Nonalcoholic Cirrhotic Patients
por: Salari, A., et al.
Publicado: (2013)

Electrocardiographic Changes in Liver Cirrhosis—Clues for Cirrhotic Cardiomyopathy
por: Toma, Letitia, et al.
Publicado: (2020)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
por: Kim, Moon Young, et al.
Publicado: (2010)

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis
por: Thompson Coon, J, et al.
Publicado: (2008)

Hepatocellular Carcinoma Surveillance and Treatment: A Way to Reduce Cancer-related Mortality in Cirrhotic Patients
por: Qian, Xiangjun, et al.
Publicado: (2019)

An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians
por: Cespiati, Annalisa, et al.
Publicado: (2023)

Spontaneous Splenic Infarcts in a Cirrhotic Patient with Primary Biliary Cirrhosis
por: Nehme, Fredy, et al.
Publicado: (2017)

Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis
por: Zhu, Xuming, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017)

Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study
por: Lewin, Jörn, et al.
Publicado: (2021)

Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
por: Mohamadnejad, Mehdi, et al.
Publicado: (2012)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
por: Essa, Abdallah, et al.
Publicado: (2023)

Hepatocellular Carcinoma Arising in Non-Cirrhotic Haemochromatosis
por: Thompson, N. P., et al.
Publicado: (1995)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Galectins in Equine Placental Disease
por: Fedorka, Carleigh E., et al.
Publicado: (2023)

On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
por: Yang, Zeyuan, et al.
Publicado: (2023)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
por: Zoheiry, Mona M, et al.
Publicado: (2015)

Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis
por: Hollenbach, Marcus, et al.
Publicado: (2017)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats
por: Yoon, Ki Tae, et al.
Publicado: (2022)

Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients
por: Hassan, Marwa, et al.
Publicado: (2022)

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study
por: Salman, Tary, et al.
Publicado: (2021)

Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
por: Traber, Peter G., et al.
Publicado: (2013)

Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3
por: Weinmann, Daniela, et al.
Publicado: (2018)

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis
por: Biselli, M, et al.
Publicado: (2015)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

A rare presentation of hepatocellular carcinoma in non-cirrhotic liver
por: Kabbage, Lamia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e84gpq7rs3di5gst59tev3iono